A Trial of Degarelix in Patients With Prostate Cancer

Clinical trial NCT00946920 · COMPLETED

Trial details

NCT number: NCT00946920
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2009-06-01
Primary completion: 2011-03-01
Enrollment: 859

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.